These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15028077)

  • 1. Implantable cardioverter defibrillators in children:
    Frias PA
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):77-8. PubMed ID: 15028077
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.
    Alexander ME; Cecchin F; Walsh EP; Triedman JK; Bevilacqua LM; Berul CI
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):72-6. PubMed ID: 15028076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrillator therapies in hypertrophic cardiomyopathy: too many swings at bad pitches?
    Kim SS; Knight BP
    J Cardiovasc Electrophysiol; 2007 May; 18(5):488-9. PubMed ID: 17343717
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy.
    Cha YM; Gersh BJ; Maron BJ; Boriani G; Spirito P; Hodge DO; Weivoda PL; Trusty JM; Friedman PA; Hammill SC; Rea RF; Shen WK
    J Cardiovasc Electrophysiol; 2007 May; 18(5):483-7. PubMed ID: 17343723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variations of ventricular arrhythmia clusters in defibrillator recipients.
    Stuber T; Eigenmann C; Delacrétaz E
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):816-20. PubMed ID: 16922996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy and proarrhythmia: weathering the storm.
    Albert CM
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):716-9. PubMed ID: 18373661
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations.
    Stephenson EA; Cecchin F; Walsh EP; Berul CI
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):69-73. PubMed ID: 15673391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators in pediatric patients: off-label devices for orphan diseases.
    Rhee EK
    J Cardiovasc Electrophysiol; 2005 Jan; 16(1):74-5. PubMed ID: 15673392
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 12. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
    Moore DR; Kok LC; Vijayaraman P
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
    [No Abstract]   [Full Text] [Related]  

  • 13. Ventricular perforation by a cardioverter lead in a small child.
    Schreiber C; Hausleiter J; Lange R
    Cardiol Young; 2004 Apr; 14(2):197. PubMed ID: 15691410
    [No Abstract]   [Full Text] [Related]  

  • 14. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
    Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
    Rassi A
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
    [No Abstract]   [Full Text] [Related]  

  • 16. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia storm after initiation of biventricular pacing: incidence, clinical characteristics, management, and outcome.
    Nayak HM; Verdino RJ; Russo AM; Gerstenfeld EP; Hsia HH; Lin D; Dixit S; Cooper JM; Callans DJ; Marchlinski FE
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):708-15. PubMed ID: 18363690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
    [No Abstract]   [Full Text] [Related]  

  • 19. Driving and implantable cardioverter-defibrillators a clearer view.
    Grubb BP
    J Am Coll Cardiol; 2007 Dec; 50(23):2241-2. PubMed ID: 18061072
    [No Abstract]   [Full Text] [Related]  

  • 20. European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance.
    Auricchio A; Gropp M; Ludgate S; Vardas P; Brugada J; Priori SG;
    Europace; 2006 May; 8(5):313-22. PubMed ID: 16635986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.